胆囊肝样腺癌的诊断与治疗现状  

Current status of diagnosis and therapy of hepatoid adenocarcinoma of the gallbladder

作　　者：王鹤霖[1] 戴朝六[1] 

机构地区：[1]中国医科大学附属盛京医院肝胆脾外科,沈阳110004

出　　处：《中华消化外科杂志》2017年第11期1163-1166,共4页Chinese Journal of Digestive Surgery

基　　金：国家自然科学基金（81701570）;辽宁省自然科学基金（2013021072）

摘　　要：胆囊肝样腺癌作为一类临床少见的肝外腺癌，具有肝样分化的特征，临床上需与肝细胞癌及胆囊癌相鉴别。目前，国内外主要以零散病例报道为主，尚缺乏系统全面的文献综述总结，本文就胆囊肝样腺癌的组织学起源、临床特点、病理组织学及免疫组织化学特点、鉴别诊断、治疗及预后等方面进行系统综述。Hepatoid ad （HAC） of the gallbladder is a variant of extrahepatic adenocarcinoma with hepatic differentiation. With similar clinicopathological presentation, the main differential diagnoses are hepatocellular carcinoma （HCC） and gallbladder carcinoma （GBC）. At present, HAC of the gallbladder have only been reported in a few researches. This article will summarize comprehensive researches on the histological origin, clinical characteristics, histopathological and immuno- histochemical characteristics, differential diagnosis, therapy and prognosis of HAC of the gallbladder.

关 键 词：胆道肿瘤 肝样腺癌 甲胎蛋白 

分 类 号：R735.7[医药卫生—肿瘤]